首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Prostate Cancer And Prostatic Diseases

Prostate Cancer And Prostatic Diseases杂志,由Springer Nature出版,于1997年创刊,Quarterly,出版语言English,ISSN:1365-7852,E-ISSN:1476-5608。

投稿咨询
Prostate Cancer And Prostatic Diseases
Prostate Cancer And Prostatic Diseases
Prostate Cancer And Prostatic Diseases
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
6.9
CiteScore
11.9
期刊收录
SCI、SCIE

Prostate Cancer And Prostatic Diseases(中文译名:《前列腺癌和前列腺疾病》),ISSN:1365-7852,EISSN:1476-5608,是Springer Nature出版的国际性学术期刊,创刊于1997年,以Quarterly形式稳定发行,2026年总发文量约95篇。该刊采用非OA开放访问,学科归属为医学 - 泌尿学与肾脏学。该刊是医学、男科学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达6.9,2025年期刊CiteScore为11.9,2025年期刊自引率约11.6%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Prostate Cancer And Prostatic Diseases长期聚焦医学、男科学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、男科学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAItaly、Canada、GERMANY (FED REP GER)、England、CHINA MAINLAND、Australia等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMDUKE UNIVERSITY、HARVARD UNIVERSITY、JOHNS HOPKINS UNIVERSITY、CEDARS SINAI MEDICAL CENTER、UNIVERSITY OF TEXAS SYSTEM、US DEPARTMENT OF VETERANS AFFAIRS等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ANDROLOGY 男科学 ONCOLOGY 肿瘤学 UROLOGY & NEPHROLOGY 泌尿学与肾脏学
1区 2区 2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学 ONCOLOGY 肿瘤学
1区 2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学 ONCOLOGY 肿瘤学
2区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 55 / 333

83.6

学科:UROLOGY & NEPHROLOGY SCIE Q1 13 / 134

90.7

学科:ONCOLOGY SCIE Q1 49 / 333

85.44

学科:UROLOGY & NEPHROLOGY SCIE Q1 15 / 134

89.18

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 56 / 328

83.1

学科:UROLOGY & NEPHROLOGY SCIE Q1 11 / 133

92.1

学科:ONCOLOGY SCIE Q1 48 / 328

85.52

学科:UROLOGY & NEPHROLOGY SCIE Q1 16 / 133

88.35


中国学者近期发文

1
Letter: The Hawthorne effect-behavioral changes from research observation-as confounder and mediator in the ERASE tria

Author:Wang, Zuomin; Liu, Qinwei; Deng, Wangdong

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41391-026-01087-7

2
Missing the full picture: Pathology, anatomy, and operator effects in HoLEP comparison

Author:Wang, Zuomin; Liu, Qinwei; Deng, Wangdong

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41391-026-01093-9

3
Perioperative outcomes of ongoing antithrombotic therapy during endoscopic surgery for benign prostatic hyperplasia: a systematic review and meta-analysis of observational studie

Author:Giulioni, Carlo; Cafarelli, Angelo; Falsetti, Federico; Spinozzi, Luca; Cormio, Angelo; Nedbal, Carlotta; Maurizi, Valentina; Yuen, Steffi Kar Kei; Gauhar, Vineet; Cindolo, Luca; Marchioni, Michele; Schips, Luigi; Castellani, Daniele

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41391-026-01098-4

4
Efficacy of the new P100 extracorporeal shock wave therapy device in the treatment of type IIIB chronic prostatitis/chronic pelvic pain syndrome: a sham treatment controlled, prospective clinical tria

Author:Zhang, Haipeng; Song, Wei; Ni, Jinliang; Zhang, Houliang; Jiang, Ziming; Yang, Guangcan; Zhang, Yifan; Wang, Keyi; Chen, Yifan; Peng, Bo

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41391-026-01072-0

5
Radical prostatectomy without prior biopsy: an initial decision-making algorithm based on PSMA PET/mpMR

Author:Li, Zhuoran; Luo, Jin; Liu, Qiwei; Jia, Yuqi; Chen, Zhiqiang; Zou, Nanxin; Li, Jinqiao; Dong, Yujie; Yang, Qiming; Wang, Chao; Jia, Zhuo; Xuan, Yundong; Ding, Xiaohui; Xu, Honghao; Liu, Baichuan; Wang, Xixi; Wang, Haiyi; Liu, Yachao; Zhang, Xu; Ci, Weimin; Niu, Shaoxi; Du, Songliang; Wang, Baojun

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41391-026-01081-z

6
Bridging the gap between PSMA-PET and reality: critical missing elements in AR-guided pelvic lymph node dissectio

Author:Wang, Zuomin; Liu, Qinwei; Deng, Wangdong

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41391-026-01080-0

7
Refining risk assessment: bridging statistical innovation and clinical realit

Author:Chen, Kaifei; Feng, Jiangfang; Chang, Jinjun

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41391-026-01088-6

8
5 T versus 3 T MRI for prostate cancer: an intra-individual prospective comparison of image quality and diagnostic performanc

Author:Xiong, Tianyu; Shen, Liting; Fan, Yunpeng; Jiang, Mingxin; Wang, Liang; Yu, Dan; Yang, Zhenghan; Niu, Yinong

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41391-026-01073-z

9
Toward a holistic understanding of Metformin's Role in oncology: responding to methodological limitations and enhancing translational relevanc

Author:Fang, Yuekun; Chen, Shengyi; Bin, Cheng

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2025; Vol. , Issue , pp. -. DOI: 10.1038/s41391-025-00991-8

10
Integrating clinical and technological perspectives to enhance predictive modeling in prostate cancer surger

Author:Chen, Shengyi; Fang, Yuekun; Cheng, Bin

Journal: PROSTATE CANCER AND PROSTATIC DISEASES. 2025; Vol. , Issue , pp. -. DOI: 10.1038/s41391-025-00978-5


在线咨询

Prostate Cancer And Prostatic Diseases

国际简称:PROSTATE CANCER P D参考译名:前列腺癌和前列腺疾病

年发文量:95 CiteScore:11.9 是否预警:否 Gold OA文章占比:34.08% 研究类文章占比:68.42%

杂志社联系方式:NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Prostate Cancer And Prostatic Diseases